Hopstem Biotechnology Inc.
1 clinical trials · Sponsor
◉ Watch Hopstem Biotechnology Inc.
| Record | Firm | Date |
|---|---|---|
| A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke (NCT06299033) | Hopstem Biotechnology Inc. | 2023-11-09 |
Track Hopstem Biotechnology Inc. automatically
Every clearance here is in the API, with alerts when new ones post.